Background. The purpose of this study was to assess the relative importance on patients' lives of multiple outcomes resulting from the management of head and neck cancer (HNC). Methods. HNC patients filled out a disease-specific quality of life (QOL) survey covering 5 domains (speech, eating, aesth
Outcomes following reirradiation of patients with head and neck cancer
✍ Scribed by David P. Goldstein; Lucy Hynds Karnell; Min Yao; G. Parker Chamberlin; Thanh X. Nguyen; Gerry F. Funk
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 128 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
This study reports the outcomes for patients with head and neck cancer who received reirradiation with palliative or curative intent.
Methods
A retrospective review of 41 patients treated with curative (n = 28) or palliative (n = 13) reirradiation was conducted. Survival was calculated from the start of the reirradiation. Radiation‐related toxicities were classified according to Radiation Therapy Oncology Group criteria. Disease‐related problems included adverse events during or after reirradiation that were not directly related to reirradiation.
Results
The observed 1‐year survival for all patients was 39.0% (23.0% palliative, 46.3% curative). Median survival for all patients was 10.2 months. Seventy‐five percent of curative and 53.8% of palliative patients had grade 3 or 4 radiation‐related toxicities and/or major disease‐related problems.
Conclusion
A second course of radiotherapy in patients with head and neck cancer should be offered with a clear understanding that survival is poor and many of these patients will suffer severe radiation‐related or disease‐related insults to their quality of life during and after treatment. © 2008 Wiley Periodicals, Inc. Head Neck, 2008
📜 SIMILAR VOLUMES
## Abstract ## Background In this retrospective investigation we analyzed outcome and toxicity after intensity‐modulated reirradiation of recurrent head and neck cancer. ## Methods Thirty‐eight patients with local recurrent head and neck cancer were evaluated. The median dose of initial radiothe
## Abstract ## Background. Treatment decisions in head and neck cancer (HNC) might involve consideration of uncertain tradeoffs of one late effect against another or increasing toxicity or residual impairment for increased chance of survival. Understanding how patients prioritize potential outcome
Background. The purpose of this study was to evaluate the outcomes of dacryocystorhinostomy (DCR) in patients with head and neck tumors. Methods. The clinical records of all 31 patients with head and neck tumors who underwent DCR for nasolacrimal duct blockage at The University of Texas M. D. Ander